Anisodine drug with clot removal for acute stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a drug called anisodine hydrobromide given alongside emergency clot-removal surgery (endovascular therapy) for acute stroke caused by a large blood clot in the brain. The goal is to see if the drug helps improve recovery and reduce disability after stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–80 years
- Recent acute stroke caused by a large blood clot in the front or middle part of the brain, confirmed by imaging
- Planned for emergency clot-removal surgery (endovascular therapy) within 24 hours
- Moderate-to-severe stroke symptoms (NIHSS score of 6 or higher)
- Relatively preserved brain tissue on baseline CT scan (ASPECTS score of 6 or higher)
- Able to function independently before the stroke (modified Rankin Scale 0–1)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a drug called human urinary kallidinogenase to standard clot-removal therapy helps people recover better after a large-vessel stroke. If you qualify, you would receive the drug or a placebo by IV along with the procedure, and doctors will monitor your recovery.
This trial tests whether giving albumin, a protein naturally found in blood, can improve recovery after a large artery stroke when given along with a procedure to remove the clot. It's for people aged 18-80 who have a stroke from a blockage in the front part of the brain and can get treatment within 24 hours.
This trial tests whether giving a clot-dissolving medication directly into the brain's blood vessels during a standard procedure (mechanical thrombectomy) can improve outcomes for people with a stroke caused by a blockage in a medium-sized artery. It may be an option for patients who arrive at the hospital within 24 hours of symptom onset and have enough salvageable brain tissue.
This trial tests a new type of catheter (called iNstroke) to remove blood clots from the brain in people having a stroke. If you are within 24 hours of a major stroke and meet certain health criteria, this study may be an option for you.
This trial tests if a clot-dissolving medicine can help people who had a mild ischemic stroke and also had a prior stroke in the last 3 months. It aims to see if the treatment is safe and effective for this specific group.
This trial tests if a procedure to remove a blood clot from the main artery in the back of the brain (basilar artery) can help people who have a large stroke. The procedure is done within 24 hours of symptom onset, and researchers want to see if it can reduce disability.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.